CN1132582C - 高含量泛西洛维片剂 - Google Patents

高含量泛西洛维片剂 Download PDF

Info

Publication number
CN1132582C
CN1132582C CN97191703A CN97191703A CN1132582C CN 1132582 C CN1132582 C CN 1132582C CN 97191703 A CN97191703 A CN 97191703A CN 97191703 A CN97191703 A CN 97191703A CN 1132582 C CN1132582 C CN 1132582C
Authority
CN
China
Prior art keywords
famciclovir
tablet
excipients
tablets
compressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97191703A
Other languages
English (en)
Chinese (zh)
Other versions
CN1208350A (zh
Inventor
迈克尔·J·格林韦
珍妮弗·M·斯莱特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Publication of CN1208350A publication Critical patent/CN1208350A/zh
Application granted granted Critical
Publication of CN1132582C publication Critical patent/CN1132582C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN97191703A 1996-01-16 1997-01-13 高含量泛西洛维片剂 Expired - Lifetime CN1132582C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9600847.9 1996-01-16
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (2)

Publication Number Publication Date
CN1208350A CN1208350A (zh) 1999-02-17
CN1132582C true CN1132582C (zh) 2003-12-31

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97191703A Expired - Lifetime CN1132582C (zh) 1996-01-16 1997-01-13 高含量泛西洛维片剂

Country Status (37)

Country Link
US (1) US6765007B1 (enExample)
EP (1) EP0874632B1 (enExample)
JP (2) JP4711360B2 (enExample)
KR (1) KR100338829B1 (enExample)
CN (1) CN1132582C (enExample)
AP (2) AP747A (enExample)
AR (1) AR005456A1 (enExample)
AT (1) ATE220910T1 (enExample)
AU (1) AU713090B2 (enExample)
BG (1) BG63488B1 (enExample)
BR (1) BR9706982A (enExample)
CY (1) CY2390B1 (enExample)
CZ (1) CZ287205B6 (enExample)
DE (1) DE69714215T2 (enExample)
DK (1) DK0874632T3 (enExample)
DZ (1) DZ2159A1 (enExample)
EA (1) EA001946B1 (enExample)
EG (1) EG23684A (enExample)
ES (1) ES2180922T3 (enExample)
GB (1) GB9600847D0 (enExample)
HU (1) HU225472B1 (enExample)
IL (1) IL124913A0 (enExample)
MX (1) MX9805713A (enExample)
MY (1) MY127527A (enExample)
NO (1) NO315689B1 (enExample)
NZ (1) NZ326769A (enExample)
OA (1) OA10812A (enExample)
PE (1) PE35498A1 (enExample)
PL (1) PL187291B1 (enExample)
PT (1) PT874632E (enExample)
SK (1) SK282132B6 (enExample)
TR (1) TR199800954T2 (enExample)
TW (1) TW434016B (enExample)
UA (1) UA63897C2 (enExample)
UY (2) UY24437A1 (enExample)
WO (1) WO1997025990A1 (enExample)
ZA (1) ZA97310B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
US8343516B2 (en) 2009-06-26 2013-01-01 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671970A1 (fr) * 1991-01-30 1992-07-31 Wellcome Found Comprimes dispersables dans l'eau.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
WO1992020816A1 (en) 1991-05-15 1992-11-26 Yale University Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671970A1 (fr) * 1991-01-30 1992-07-31 Wellcome Found Comprimes dispersables dans l'eau.

Also Published As

Publication number Publication date
UA63897C2 (en) 2004-02-16
AP9801298A0 (en) 1998-09-30
MY127527A (en) 2006-12-29
DE69714215D1 (de) 2002-08-29
EP0874632B1 (en) 2002-07-24
ES2180922T3 (es) 2003-02-16
HU225472B1 (en) 2006-12-28
BG63488B1 (bg) 2002-03-29
AU713090B2 (en) 1999-11-25
NO315689B1 (no) 2003-10-13
KR19990077229A (ko) 1999-10-25
TR199800954T2 (xx) 1998-10-21
US6765007B1 (en) 2004-07-20
PL327922A1 (en) 1999-01-04
UY24437A1 (es) 1997-06-06
BG102638A (bg) 1999-07-30
DZ2159A1 (fr) 2002-12-01
EA001946B1 (ru) 2001-10-22
UY24556A1 (es) 2001-08-27
TW434016B (en) 2001-05-16
DE69714215T2 (de) 2003-01-23
JP4711360B2 (ja) 2011-06-29
AP9700911A0 (en) 1997-01-31
HUP9901021A3 (en) 2000-08-28
CZ287205B6 (en) 2000-10-11
PT874632E (pt) 2002-10-31
ZA97310B (en) 1997-10-23
CY2390B1 (en) 2004-09-10
NO983259D0 (no) 1998-07-15
CZ225498A3 (cs) 1998-12-16
OA10812A (en) 2003-01-29
HK1016473A1 (en) 1999-11-05
IL124913A0 (en) 1999-01-26
AU1541897A (en) 1997-08-11
SK282132B6 (sk) 2001-11-06
EP0874632A1 (en) 1998-11-04
EG23684A (en) 2007-05-09
MX9805713A (es) 1998-10-31
EA199800573A1 (ru) 1999-02-25
AP1114A (en) 2002-10-18
NO983259L (no) 1998-07-15
DK0874632T3 (da) 2002-11-11
CN1208350A (zh) 1999-02-17
NZ326769A (en) 2000-05-26
KR100338829B1 (ko) 2002-07-18
ATE220910T1 (de) 2002-08-15
SK95698A3 (en) 1999-01-11
GB9600847D0 (en) 1996-03-20
AP747A (en) 1999-05-03
AR005456A1 (es) 1999-06-23
JP2009091362A (ja) 2009-04-30
BR9706982A (pt) 1999-07-20
WO1997025990A1 (en) 1997-07-24
PL187291B1 (pl) 2004-06-30
JP2000503311A (ja) 2000-03-21
PE35498A1 (es) 1998-08-07
HUP9901021A2 (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
US4839176A (en) Therapeutic agents
EP2702989B1 (en) Stable pharmaceutical composition
WO2009101940A1 (ja) 溶出性の改善された錠剤
SA112330689B1 (ar) صيغة كبسولات تشتمل على مونتليوكاست وليڤوستيريزين
CN1132582C (zh) 高含量泛西洛维片剂
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
CN1112929C (zh) 含有咪唑拉汀的缓释药物制剂
IE75887B1 (en) High-content ibuprofen lysinate pharmaceutical formulation
EP1210939B1 (en) Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof
RU2318496C2 (ru) Содержащая свехчистую флудару пероральная композиция с быстрым высвобождением действующего вещества
CN110251476B (zh) 一种恩曲他滨替诺福韦药物组合物
JP2006327943A (ja) 経時的溶出遅延を抑制したテイストマスク錠剤
HK1016473B (en) High-content famciclovir tablets
EP3372227A1 (en) Tablet formulation of adefovir dipivoxil
HK1077741B (en) Oral fludara of high-purity formulation with quick release of active ingredient

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: BELLSOS INTELLECTUAL PROPERTY CO., LTD.

Free format text: FORMER OWNER: SMITHKLINE BEECHAM PLC

Effective date: 20010831

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20010831

Address after: Bermuda Hamilton

Applicant after: Novartis Int Pharm Ltd.

Address before: British Meader Sykes

Applicant before: Smihkline Beecham PLC

C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20031231

EXPY Termination of patent right or utility model